417 related articles for article (PubMed ID: 25550930)
21. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects.
Ampuero J; Aller R; Gallego-Durán R; Crespo J; Abad J; González-Rodríguez Á; Gómez-Camarero J; Caballería J; Lo Iacono O; Ibañez L; García-Samaniego J; Martín-Mateos R; Francés R; Fernández-Rodríguez C; Diago M; Soriano G; Andrade RJ; Latorre R; Jorquera F; Morillas RM; Escudero D; Estévez P; Hernández-Guerra M; Augustín S; Pareja-Megia MJ; Banales JM; Aspichueta P; Benlloch S; Rosales JM; Salmerón J; Turnes J; Romero-Gómez M;
Liver Int; 2021 Sep; 41(9):2076-2086. PubMed ID: 33896100
[TBL] [Abstract][Full Text] [Related]
22. The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations.
Ali AA; Fouda A; Abdelaziz ES; Abdelkawy K; Ahmed MH
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e954-e960. PubMed ID: 34907983
[TBL] [Abstract][Full Text] [Related]
23. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
Pimentel CF; Jiang ZG; Otsubo T; Feldbrügge L; Challies TL; Nasser I; Robson S; Afdhal N; Lai M
Dig Dis Sci; 2016 Mar; 61(3):905-12. PubMed ID: 26462489
[TBL] [Abstract][Full Text] [Related]
24. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
25. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.
De A; Duseja A
J Clin Exp Hepatol; 2020; 10(3):255-262. PubMed ID: 32405182
[TBL] [Abstract][Full Text] [Related]
26. Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.
Fujii Y; Nouso K; Matsushita H; Kariyama K; Sakurai T; Takahashi Y; Chiba H; Hui SP; Ito Y; Ohta M; Okada H
J Appl Lab Med; 2020 Nov; 5(6):1206-1215. PubMed ID: 32674154
[TBL] [Abstract][Full Text] [Related]
27. The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease.
Nakamura A; Yamamoto K; Takeda R; Yamada R; Kubo A; Morikawa K; Ando S; Shimazaki T; Izumi T; Umemura M; Kitagataya T; Shigesawa T; Suzuki K; Kimura M; Nakai M; Sho T; Suda G; Natsuizaka M; Ogawa K; Ohnishi S; Sugiyama T; Takeda H; Sakamoto N
Hepatol Res; 2022 Jun; 52(6):508-521. PubMed ID: 35129841
[TBL] [Abstract][Full Text] [Related]
28. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Suppli MP; Rigbolt KTG; Veidal SS; Heebøll S; Eriksen PL; Demant M; Bagger JI; Nielsen JC; Oró D; Thrane SW; Lund A; Strandberg C; Kønig MJ; Vilsbøll T; Vrang N; Thomsen KL; Grønbæk H; Jelsing J; Hansen HH; Knop FK
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G462-G472. PubMed ID: 30653341
[TBL] [Abstract][Full Text] [Related]
29. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.
Loomba R; Quehenberger O; Armando A; Dennis EA
J Lipid Res; 2015 Jan; 56(1):185-92. PubMed ID: 25404585
[TBL] [Abstract][Full Text] [Related]
30. Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients.
Diab DL; Yerian L; Schauer P; Kashyap SR; Lopez R; Hazen SL; Feldstein AE
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1249-54. PubMed ID: 18995215
[TBL] [Abstract][Full Text] [Related]
31. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
[TBL] [Abstract][Full Text] [Related]
33. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
Alkhouri N; Johnson C; Adams L; Kitajima S; Tsuruno C; Colpitts TL; Hatcho K; Lawitz E; Lopez R; Feldstein AE
PLoS One; 2018; 13(8):e0202226. PubMed ID: 30161179
[TBL] [Abstract][Full Text] [Related]
34. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
[TBL] [Abstract][Full Text] [Related]
35. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Kage M; Aishima S; Kusano H; Yano H
J Med Ultrason (2001); 2020 Oct; 47(4):549-554. PubMed ID: 33136250
[TBL] [Abstract][Full Text] [Related]
36. Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis.
Xu G; Wang YM; Ying MM; Chen SD; Li ZR; Ma HL; Zheng MH; Wu J; Ding C
Clin Mol Hepatol; 2021 Apr; 27(2):329-345. PubMed ID: 33465844
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.
Kado A; Tsutsumi T; Enooku K; Fujinaga H; Ikeuchi K; Okushin K; Moriya K; Yotsuyanagi H; Koike K
J Gastroenterol; 2019 Aug; 54(8):730-741. PubMed ID: 30830270
[TBL] [Abstract][Full Text] [Related]
38. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease.
Malik R; Chang M; Bhaskar K; Nasser I; Curry M; Schuppan D; Byrnes V; Afdhal N
J Gastroenterol Hepatol; 2009 Apr; 24(4):564-8. PubMed ID: 19378390
[TBL] [Abstract][Full Text] [Related]
39. Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.
Becker PP; Rau M; Schmitt J; Malsch C; Hammer C; Bantel H; Müllhaupt B; Geier A
PLoS One; 2015; 10(11):e0142661. PubMed ID: 26565986
[TBL] [Abstract][Full Text] [Related]
40. Validation of the non-alcoholic fatty liver disease activity score.
Hjelkrem M; Stauch C; Shaw J; Harrison SA
Aliment Pharmacol Ther; 2011 Jul; 34(2):214-8. PubMed ID: 21585409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]